These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28025240)

  • 1. Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds.
    Tseng HF; Sy LS; Ackerson BK; Hechter RC; Tartof SY; Haag M; Slezak JM; Luo Y; Fischetti CA; Takhar HS; Miao Y; Cunnington M; Solano Z; Jacobsen SJ
    Pediatrics; 2017 Jan; 139(1):. PubMed ID: 28025240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 Years.
    Tartof SY; Sy LS; Ackerson BK; Hechter RC; Haag M; Slezak JM; Luo Y; Fischetti CA; Takhar HS; Miao Y; Solano Z; Jacobsen SJ; Tseng HF
    Pediatr Infect Dis J; 2017 Nov; 36(11):1087-1092. PubMed ID: 28719502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children.
    Hansen J; Zhang L; Eaton A; Baxter R; Robertson CA; Decker MD; Greenberg DP; Bassily E; Klein NP
    Vaccine; 2018 Apr; 36(16):2133-2138. PubMed ID: 29550195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine.
    Hansen J; Zhang L; Klein NP; Robertson CA; Decker MD; Greenberg DP; Bassily E; Baxter R
    Vaccine; 2017 Dec; 35(49 Pt B):6879-6884. PubMed ID: 28941623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.
    Abdelnour A; Silas PE; Lamas MR; Aragón CF; Chiu NC; Chiu CH; Acuña TH; Castrejón Tde L; Izu A; Odrljin T; Smolenov I; Hohenboken M; Dull PM
    Vaccine; 2014 Feb; 32(8):965-72. PubMed ID: 24397906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents.
    Baxter R; Reisinger K; Block SL; Izu A; Odrljin T; Dull P
    J Pediatr; 2014 Jun; 164(6):1409-15.e4. PubMed ID: 24657122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bell's palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series.
    Wijnans L; Dodd CN; Weibel D; Sturkenboom M
    PLoS One; 2017; 12(5):e0175539. PubMed ID: 28467420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of concomitant administration of a combined hepatitis A/B vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adults.
    Alberer M; Burchard G; Jelinek T; Reisinger EC; Meyer S; Forleo-Neto E; Dagnew AF; Arora AK
    J Travel Med; 2015; 22(2):105-14. PubMed ID: 25483566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current safety issues with quadrivalent meningococcal conjugate vaccines.
    Myers TR; McNeil MM
    Hum Vaccin Immunother; 2018 May; 14(5):1175-1178. PubMed ID: 28934061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
    Jackson LA; Baxter R; Reisinger K; Karsten A; Shah J; Bedell L; Dull PM;
    Clin Infect Dis; 2009 Jul; 49(1):e1-10. PubMed ID: 19476428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015.
    Myers TR; McNeil MM; Ng CS; Li R; Lewis PW; Cano MV
    Vaccine; 2017 Mar; 35(14):1758-1763. PubMed ID: 28262331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.
    Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Hlavata LC; Forleo-Neto E; Dagnew AF; Arora AK
    J Travel Med; 2015; 22(1):48-56. PubMed ID: 25308927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study.
    Dbaibo G; Tinoco Favila JC; Traskine M; Jastorff A; Van der Wielen M
    Vaccine; 2018 Jun; 36(28):4102-4111. PubMed ID: 29784470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old.
    Becerra-Culqui TA; Sy LS; Ackerson BK; Slezak JM; Luo Y; Fischetti CA; Ohadike YU; Curina C; Pellegrini M; Solano Z; Tartof SY; Tseng HF
    Vaccine; 2020 Jan; 38(2):228-234. PubMed ID: 31648912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age.
    Halperin SA; Gupta A; Jeanfreau R; Klein NP; Reisinger K; Walter E; Bedell L; Gill C; Dull PM
    Vaccine; 2010 Nov; 28(50):7865-72. PubMed ID: 20943209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine and Commonly Administered Vaccines After Coadministration.
    Gasparini R; Tregnaghi M; Keshavan P; Ypma E; Han L; Smolenov I
    Pediatr Infect Dis J; 2016 Jan; 35(1):81-93. PubMed ID: 26398743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal conjugate vaccine safety surveillance in the Vaccine Safety Datalink using a tree-temporal scan data mining method.
    Li R; Weintraub E; McNeil MM; Kulldorff M; Lewis EM; Nelson J; Xu S; Qian L; Klein NP; Destefano F
    Pharmacoepidemiol Drug Saf; 2018 Apr; 27(4):391-397. PubMed ID: 29446176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults.
    Pace D
    Future Microbiol; 2010 Nov; 5(11):1629-40. PubMed ID: 21133685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers.
    Klein NP; Shepard J; Bedell L; Odrljin T; Dull P
    Vaccine; 2012 Jun; 30(26):3929-36. PubMed ID: 22504039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.